The Pharma Letter |
FDA to Investigate Diabetes Drug Saxagliptin for Possible Heart Failure Risk
U.S. News & World Report TUESDAY, Feb. 11, 2014 (HealthDay News) — The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users. In a statement, the … FDA Investigating Heart Failure Risk Linked To OnglyzaForbes FDA to review heart failure risk associated with saxagliptinHealio FDA to review heart failure risk with AstraZeneca diabetes drugThe Pharma Letter Clinical Endocrinology News Digital Network –Science World Report –MedPage Today all 39 news articles » |
FDA Investigating Heart Failure Risks with Saxagliptin – Drug Discovery & Development
Drug Discovery & Development |
FDA Investigating Heart Failure Risks with Saxagliptin
Drug Discovery & Development The U.S. Food and Drug Administration (FDA) has requested clinical trial data from the manufacturer of saxagliptin, which is co-developed by AstraZeneca and Bristol-Myers Squibb Co., to investigate a possible association between use of the type 2 … |
Allogeneic HSCT increased risk for oral, esophageal cancers – Healio
Allogeneic HSCT increased risk for oral, esophageal cancersHealioAllogeneic hematopoietic stem cell transplantation doubled the risk for secondary solid cancers and further increased the risk for oral and esophageal cancers, according to study results….
Children's Medical Center to Host 23rd Annual 'Be The Match' Donor Registry … – The Herald | HeraldOnline.com (press release)
|
Children’s Medical Center to Host 23rd Annual ‘Be The Match’ Donor Registry …
The Herald | HeraldOnline.com (press release) Another development has been the use of blood and marrow stem cell transplant to treat and even cure children with severe sickle cell disease, one of the most common serious genetic disorders in the world. Sickle cell disease is most commonly found … |
More chemo for tot suffering from aggressive cancer – Yorkshire Evening Post
Yorkshire Evening PostMore chemo for tot suffering from aggressive cancerYorkshire Evening PostThen she underwent high dose chemotherapy in preparation for a stem cell transplant, and also underwent radiotherapy. Now she faces two months of further che…
Heart Failure Awareness – WALA-TV FOX10
|
Heart Failure Awareness
WALA-TV FOX10 Did you know it’s Heart Failure Awareness Week? Heart failure is a condition that affects nearly five million Americans of all ages and is responsible for more hospitalizations than all forms of cancer combined. Dr. Partick Murphy, a Cardiologist at … |
Children's Medical Center to Host 23 rd Annual 'Be The Match' Donor Registry … – Business Wire (press release)
|
Children’s Medical Center to Host 23 rd Annual ‘Be The Match’ Donor Registry …
Business Wire (press release) Another development has been the use of blood and marrow stem cell transplant to treat and even cure children with severe sickle cell disease, one of the most common serious genetic disorders in the world. Sickle cell disease is most commonly found … |
Resilience in parents of children undergoing stem cell transplant – Medical Xpress
|
Resilience in parents of children undergoing stem cell transplant
Medical Xpress However, a study recently published in the journal Biology of Blood and Marrow Transplantation shows that in the case of a child’s stem cell transplant, parents feel increased distress at the time of the procedure, but eventually recover to normal … Children’s Medical Center to Host 23rd Annual ‘Be The Match’ Donor Registry …The Herald | HeraldOnline.com (press release) |
Triple therapy resulted in reduced fibrosis among patients with HCV – Healio
Triple therapy resulted in reduced fibrosis among patients with HCVHealioLiver transplant patients with recurrent hepatitis C virus displayed less fibrotic progression when treated with tacrolimus, azathioprine and steroids compared with those patients…
Gilead seeks approval for first-ever oral Hepatitis C drug – Seattle Post Intelligencer (blog)
Gilead seeks approval for first-ever oral Hepatitis C drugSeattle Post Intelligencer (blog)Gilead is also taking heat internationally for its tentative plans to bring Sovaldi to India and other developing countries at a fraction of the U.S. price, abou…